# The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

> **NCT01706939** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 23 (actual)

## Conditions studied

- Squamous Cell Carcinomas

## Interventions

- **RADIATION:** Reduced Dose Radiation
- **RADIATION:** Standard Dose Radiation
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT01706939
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-09-01
- **Primary completion:** 2020-04-01
- **Final completion:** 2035-05-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01706939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01706939, "The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT01706939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*